A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering ...

A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering ...

A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic ...

In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

ORLANDO -- Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

Ongoing research aims to delineate its full spectrum of activity, optimal strategies, and the breadth of its implications.

Here, the authors develop a yeast platform that mimics osteoblast mechanisms to produce the high-value hydroxyapatite directly from urine.

Here they identify a selective PRC1.1 inhibitor, iBP, that treats bone loss by improving osteoblast function. iBP releases repression of Wnt/β-catenin signaling, enhancing bone formation and ...

Jan. 21, 2025 — The discovery of a family with sequence similarity 102 member A (Fam102a) protein as a novel bone remodeling factor that regulates both osteoclast and osteoblast differentiation ...